These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18805692)

  • 1. Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.
    Bridges TM; Brady AE; Kennedy JP; Daniels RN; Miller NR; Kim K; Breininger ML; Gentry PR; Brogan JT; Jones CK; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5439-42. PubMed ID: 18805692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.
    Miller NR; Daniels RN; Bridges TM; Brady AE; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5443-7. PubMed ID: 18829311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further exploration of M₁ allosteric agonists: subtle structural changes abolish M₁ allosteric agonism and result in pan-mAChR orthosteric antagonism.
    Sheffler DJ; Sevel C; Le U; Lovell KM; Tarr JC; Carrington SJ; Cho HP; Digby GJ; Niswender CM; Conn PJ; Hopkins CR; Wood MR; Lindsley CW
    Bioorg Med Chem Lett; 2013 Jan; 23(1):223-7. PubMed ID: 23200253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric site.
    Jacobson MA; Kreatsoulas C; Pascarella DM; O'Brien JA; Sur C
    Mol Pharmacol; 2010 Oct; 78(4):648-57. PubMed ID: 20660086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptor.
    Keov P; Valant C; Devine SM; Lane JR; Scammells PJ; Sexton PM; Christopoulos A
    Mol Pharmacol; 2013 Sep; 84(3):425-37. PubMed ID: 23798605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats.
    Jones CK; Brady AE; Davis AA; Xiang Z; Bubser M; Tantawy MN; Kane AS; Bridges TM; Kennedy JP; Bradley SR; Peterson TE; Ansari MS; Baldwin RM; Kessler RM; Deutch AY; Lah JJ; Levey AI; Lindsley CW; Conn PJ
    J Neurosci; 2008 Oct; 28(41):10422-33. PubMed ID: 18842902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor.
    Mistry SN; Valant C; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
    J Med Chem; 2013 Jun; 56(12):5151-72. PubMed ID: 23718562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold.
    Sharma S; Rodriguez AL; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4098-101. PubMed ID: 18550372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel BQCA- and TBPB-Derived M
    Schramm S; Agnetta L; Bermudez M; Gerwe H; Irmen M; Holze J; Littmann T; Wolber G; Tränkle C; Decker M
    ChemMedChem; 2019 Jul; 14(14):1349-1358. PubMed ID: 31166078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor.
    Abdul-Ridha A; Lane JR; Mistry SN; López L; Sexton PM; Scammells PJ; Christopoulos A; Canals M
    J Biol Chem; 2014 Nov; 289(48):33701-11. PubMed ID: 25326383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the binding site of novel selective positive allosteric modulators at the M
    Khajehali E; Valant C; Jörg M; Tobin AB; Conn PJ; Lindsley CW; Sexton PM; Scammells PJ; Christopoulos A
    Biochem Pharmacol; 2018 Aug; 154():243-254. PubMed ID: 29777683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bitopic Binding Mode of an M
    Bradley SJ; Molloy C; Bundgaard C; Mogg AJ; Thompson KJ; Dwomoh L; Sanger HE; Crabtree MD; Brooke SM; Sexton PM; Felder CC; Christopoulos A; Broad LM; Tobin AB; Langmead CJ
    Mol Pharmacol; 2018 Jun; 93(6):645-656. PubMed ID: 29695609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and SAR of muscarinic receptor subtype 1 (M1) allosteric activators from a molecular libraries high throughput screen. Part 1: 2,5-dibenzyl-2H-pyrazolo[4,3-c]quinolin-3(5H)-ones as positive allosteric modulators.
    Han C; Chatterjee A; Noetzel MJ; Panarese JD; Smith E; Chase P; Hodder P; Niswender C; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2015 Jan; 25(2):384-8. PubMed ID: 25435150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor.
    Abdul-Ridha A; López L; Keov P; Thal DM; Mistry SN; Sexton PM; Lane JR; Canals M; Christopoulos A
    J Biol Chem; 2014 Feb; 289(9):6067-79. PubMed ID: 24443568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric modulation of M1 muscarinic acetylcholine receptor internalization and subcellular trafficking.
    Yeatman HR; Lane JR; Choy KH; Lambert NA; Sexton PM; Christopoulos A; Canals M
    J Biol Chem; 2014 May; 289(22):15856-66. PubMed ID: 24753247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and SAR of selective muscarinic acetylcholine receptor subtype 1 (M1 mAChR) antagonists.
    Lewis LM; Sheffler D; Williams R; Bridges TM; Kennedy JP; Brogan JT; Mulder MJ; Williams L; Nalywajko NT; Niswender CM; Weaver CD; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Feb; 18(3):885-90. PubMed ID: 18178088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of multiple allosteric sites on the M1 muscarinic acetylcholine receptor.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    FEBS Lett; 2005 Dec; 579(30):6726-32. PubMed ID: 16310776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress toward a high-affinity allosteric enhancer at muscarinic M1 receptors.
    Lazareno S; Popham A; Birdsall NJ
    J Mol Neurosci; 2003; 20(3):363-7. PubMed ID: 14501021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAM.
    Bridges TM; Kennedy JP; Cho HP; Breininger ML; Gentry PR; Hopkins CR; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2010 Jan; 20(2):558-62. PubMed ID: 20004578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of analogues of benzyl quinolone carboxylic acid (BQCA) designed to bind irreversibly to an allosteric site of the M ₁ muscarinic acetylcholine receptor.
    Davie BJ; Valant C; White JM; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
    J Med Chem; 2014 Jun; 57(12):5405-18. PubMed ID: 24856614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.